REG - Feedback PLC - CDC Contract Awarded by Queen Victoria Hospital

FeedbackAnnouncement

01/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240701:nRSA4616Ua&default-theme=true

RNS Number : 4616U  Feedback PLC  01 July 2024

Feedback plc

 

Feedback Wins CDC Contract With Queen Victoria Hospital

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, is pleased to announce that it has been awarded a
contract by Queen Victoria Hospital NHS Foundation Trust ("QVH") to provide
its Bleepa Community Diagnostics Centre ("CDC") solution.

 

This contract, which is worth £495,000 for an initial 12-month term with the
ability to extend by another 12 months, has been awarded to Feedback as the
successful bidder in a procurement process launched by QVH in November 2023,
to provide a digital infrastructure to facilitate patient specific pathways
through the CDC, linking both primary and secondary care settings.

 

Feedback has already delivered cost and time savings at QVH initially through
its pilot programme. The pilot has provided a substantial reduction in wait
time compared to the national 18-week referral-to-treatment (RTT) target,
without the need for additional clinical staff. This contract award provides
the opportunity for Feedback to continue to deliver the core digital
infrastructure required for the CDCs to reduce the elective care backlog and
deliver a programme for the maximum benefit of staff, patients and the wider
NHS. The success of Bleepa at QVH provides a valuable case study for the wider
market across the UK.

 

Dr Tom Oakley, CEO Feedback plc said:

 

"We are extremely pleased to announce that after two years of piloting our CDC
solution with QVH we have been awarded a contract for the Bleepa platform.
This contract will allow us to now expand the service offering to multiple GP
practices and move beyond the breathlessness pathway to look at other
specialty areas.

 

"This contract award is a compelling validation of our technology. QVH is an
example that speaks to the rest of the NHS and is the pioneer of the
symptom-based pathway on Bleepa, an approach which has demonstrated huge
potential to cut wait times and improve care for patients. This contract will
give others the confidence to progress with this care model and our platform,
allowing us to now move forward to capture both the regional and national
opportunity in front of us and ultimately to bring better, faster care to
patients across the UK."

 

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 as it forms part of UK law by virtue of the
European Union (Withdrawal) Act 2018.

 

-Ends-

 

Enquiries:

 

 Feedback plc                                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                                             IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Liberum Limited (NOMAD and Broker)                  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                                        07748 325 236 or 07407 020 470

 

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for
patients. We design products that enhance clinician access to patient data and
to their colleagues. Our unique approach centres around individual patient
episodes, into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available to
clinicians in multiple settings, in a format that enables them to meaningfully
interact with it, providing flexibility to clinicians and free movement of
patients between provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment, with greater connectivity
across organisations.

 

Our products Bleepa® and CareLocker® work together to deliver unparalleled
value to our customers. Bleepa® is our application layer and sits on top of
CareLocker® as our data layer. Bleepa® is a clinician facing platform that
displays clinical results from a patient's CareLocker® at a certified and
regulated quality, that is suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure, auditable chat
interface that links back to the patient medical record. The CareLocker® data
storage model is built around the patient. Our vision is one where relevant
clinical data is always available to the patient as well as to any care
setting that they may attend - a federated data architecture with the patient
as the tenant.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based model is expected to provide increasing levels of
revenue visibility as the Company grows its customer base.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTEAXKPAFSLEFA